» Articles » PMID: 32139745

A Prolonged Multispecies Outbreak of IMP-6 Carbapenemase-producing Enterobacterales Due to Horizontal Transmission of the IncN Plasmid

Abstract

A multispecies outbreak of IMP-6 carbapenemase-producing Enterobacterales (IMP-6-CPE) occurred at an acute care hospital in Japan. This study was conducted to understand the mechanisms of IMP-6-CPE transmission by pulsed-field gel electrophoresis (PFGE), multilocus sequence typing and whole-genome sequencing (WGS), and identify risk factors for IMP-6-CPE acquisition in patients who underwent abdominal surgery. Between July 2013 and March 2014, 22 hospitalized patients infected or colonized with IMP-6-CPE (Escherichia coli [n = 8], Klebsiella oxytoca [n = 5], Enterobacter cloacae [n = 5], Klebsiella pneumoniae [n = 3] and Klebsiella aerogenes [n = 1]) were identified. There were diverse PFGE profiles and sequence types (STs) in most of the species except for K. oxytoca. All isolates of K. oxytoca belonged to ST29 with similar PFGE profiles, suggesting their clonal transmission. Plasmid analysis by WGS revealed that all 22 isolates but one shared a ca. 50-kb IncN plasmid backbone with bla suggesting interspecies gene transmission, and typing of plasmids explained epidemiological links among cases. A case-control study showed pancreatoduodenectomy, changing drains in fluoroscopy room, continuous peritoneal lavage and enteric fistula were associated with IMP-6-CPE acquisition among the patients. Plasmid analysis of isolates in an outbreak of IMP-6-CPE suggested interspecies gene transmission and helped to clarify hidden epidemiological links between cases.

Citing Articles

Molecular Epidemiological Characteristics of -Carrying ST-11 in Hospitalized Patients.

Xue Y, Zhang D, Du S, Chen D, Liu S, Peng T Infect Drug Resist. 2025; 18():171-184.

PMID: 39803303 PMC: 11725253. DOI: 10.2147/IDR.S482713.


Clinical pilot of bacterial transcriptional profiling as a combined genotypic and phenotypic antimicrobial susceptibility test.

Young E, Roach D, Martinsen M, McGrath G, Holbrook N, Cho H J Clin Microbiol. 2024; 62(11):e0099724.

PMID: 39431823 PMC: 11559010. DOI: 10.1128/jcm.00997-24.


Prevalence of carbapenem-resistant Enterobacterales with predominance in hospitals from 2018 to 2021 in Nara, Japan.

Kishi R, Nakano R, Nakano A, Harimoto T, Taniguchi R, Ando S JAC Antimicrob Resist. 2024; 6(4):dlae135.

PMID: 39165366 PMC: 11334064. DOI: 10.1093/jacamr/dlae135.


Clinical Pilot of Bacterial Transcriptional Profiling as a Combined Genotypic and Phenotypic Antimicrobial Susceptibility Test.

Young E, Roach D, Martinsen M, McGrath G, Holbrook N, Cho H medRxiv. 2024; .

PMID: 39040176 PMC: 11261942. DOI: 10.1101/2024.07.10.24310021.


Molecular Epidemiology of Carbapenem-Resistant in Japan.

Takei K, Ogawa M, Sakata R, Kanamori H Int J Mol Sci. 2024; 25(8).

PMID: 38674079 PMC: 11049973. DOI: 10.3390/ijms25084494.


References
1.
Logan L, Weinstein R . The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. J Infect Dis. 2017; 215(suppl_1):S28-S36. PMC: 5853342. DOI: 10.1093/infdis/jiw282. View

2.
Nordmann P, Naas T, Poirel L . Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011; 17(10):1791-8. PMC: 3310682. DOI: 10.3201/eid1710.110655. View

3.
Mathers A, Peirano G, Pitout J . The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev. 2015; 28(3):565-91. PMC: 4405625. DOI: 10.1128/CMR.00116-14. View

4.
Nicolas-Chanoine M, Bertrand X, Madec J . Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014; 27(3):543-74. PMC: 4135899. DOI: 10.1128/CMR.00125-13. View

5.
Cornaglia G, Giamarellou H, Rossolini G . Metallo-β-lactamases: a last frontier for β-lactams?. Lancet Infect Dis. 2011; 11(5):381-93. DOI: 10.1016/S1473-3099(11)70056-1. View